RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 134 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,829,000 | -2.6% | 1,550,204 | -6.6% | 0.00% | – |
| Q2 2022 | $1,877,000 | -62.2% | 1,660,402 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $4,965,000 | +17.7% | 1,660,402 | +4.3% | 0.00% | 0.0% |
| Q4 2021 | $4,217,000 | -17.4% | 1,591,192 | +13.2% | 0.00% | 0.0% |
| Q3 2021 | $5,105,000 | -83.3% | 1,406,200 | -80.0% | 0.00% | -80.0% |
| Q2 2021 | $30,582,000 | +44.0% | 7,046,570 | +13.5% | 0.01% | +25.0% |
| Q1 2021 | $21,242,000 | -45.8% | 6,211,072 | -44.5% | 0.00% | -42.9% |
| Q4 2020 | $39,195,000 | +19.0% | 11,198,571 | -18.4% | 0.01% | 0.0% |
| Q3 2020 | $32,928,000 | +15.2% | 13,719,993 | -12.2% | 0.01% | +16.7% |
| Q2 2020 | $28,587,000 | +16.7% | 15,621,191 | -0.6% | 0.01% | 0.0% |
| Q1 2020 | $24,506,000 | -31.9% | 15,709,067 | -6.5% | 0.01% | -25.0% |
| Q4 2019 | $35,968,000 | -12.6% | 16,807,261 | -23.6% | 0.01% | -11.1% |
| Q3 2019 | $41,137,000 | -32.4% | 21,998,116 | -5.6% | 0.01% | -30.8% |
| Q2 2019 | $60,843,000 | +1.2% | 23,311,375 | -0.3% | 0.01% | -7.1% |
| Q1 2019 | $60,109,000 | +12.0% | 23,388,484 | +0.3% | 0.01% | +7.7% |
| Q4 2018 | $53,656,000 | -28.2% | 23,328,436 | +0.2% | 0.01% | -18.8% |
| Q3 2018 | $74,743,000 | +17.5% | 23,284,515 | +3.6% | 0.02% | +14.3% |
| Q2 2018 | $63,630,000 | -12.8% | 22,483,640 | +9.1% | 0.01% | -17.6% |
| Q1 2018 | $72,965,000 | -7.3% | 20,611,455 | +1.6% | 0.02% | 0.0% |
| Q4 2017 | $78,745,000 | +105.8% | 20,295,036 | +34.7% | 0.02% | +88.9% |
| Q3 2017 | $38,261,000 | -1.0% | 15,063,236 | +6.4% | 0.01% | 0.0% |
| Q2 2017 | $38,635,000 | -15.7% | 14,152,051 | +2.2% | 0.01% | -18.2% |
| Q1 2017 | $45,823,000 | +82.3% | 13,843,629 | +31.1% | 0.01% | +83.3% |
| Q4 2016 | $25,135,000 | +42.2% | 10,561,239 | +119.3% | 0.01% | +50.0% |
| Q3 2016 | $17,675,000 | +55.0% | 4,816,349 | -5.8% | 0.00% | +33.3% |
| Q2 2016 | $11,405,000 | +7.5% | 5,114,176 | +0.3% | 0.00% | 0.0% |
| Q1 2016 | $10,607,000 | -42.4% | 5,099,534 | -16.2% | 0.00% | -40.0% |
| Q4 2015 | $18,429,000 | +27.2% | 6,082,344 | +3.7% | 0.01% | +25.0% |
| Q3 2015 | $14,493,000 | -9.6% | 5,867,694 | +17.4% | 0.00% | 0.0% |
| Q2 2015 | $16,040,000 | -8.7% | 4,996,564 | +1.5% | 0.00% | -20.0% |
| Q1 2015 | $17,575,000 | +57.5% | 4,923,234 | +0.1% | 0.01% | +66.7% |
| Q4 2014 | $11,162,000 | +16.5% | 4,916,925 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $9,582,000 | -57.1% | 4,939,410 | -19.8% | 0.00% | -50.0% |
| Q2 2014 | $22,349,000 | +28.7% | 6,156,658 | +37.6% | 0.01% | +20.0% |
| Q1 2014 | $17,362,000 | +34.3% | 4,474,598 | -1.4% | 0.01% | +25.0% |
| Q4 2013 | $12,931,000 | -32.6% | 4,537,178 | -15.3% | 0.00% | -33.3% |
| Q3 2013 | $19,184,000 | -37.2% | 5,358,678 | -41.4% | 0.01% | -40.0% |
| Q2 2013 | $30,551,000 | – | 9,147,099 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |